Online citations, reference lists, and bibliographies.

Angiopathie Amyloïde Cérébrale Ou Atteinte Des Microvaisseaux Cérébraux En Rapport Avec L’HTA : Un Challenge Clinique

I. Rachdi, Fatiha Daoud Fatiha Daoud, Hana Zoubeidi, Yosra Fekih, Zohra Aydi, Basma Ben Dhaou, Fatma Boussema
Published 2019 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Resume L’angiopathie amyloide cerebrale (AAC), est une entite caracterisee par des depots de substance amyloide dans la paroi des vaisseaux cerebraux leptomeninges. Elle constitue la 2e cause d’hemorragies cerebrales primitives chez les sujets ages. Le diagnostic differentiel entre AAC et l’atteinte des microvaisseaux en rapport avec l’HTA est difficile et represente un vrai challenge pour le clinicien. Nous rapportons deux observations d’atteinte des microvaisseaux cerebraux revelee par une HTA maligne.
This paper references
10.1159/000330643
Recurrent Stroke after Lobar and Deep Intracerebral Hemorrhage: A Hospital-Based Cohort Study
Christian Weimar (2011)
10.1038/jhh.2015.112
From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency
Augustin Cremer (2016)
10.1212/WNL.0b013e3181eee40f
Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy
A. Biffi (2010)
10.1136/jnnp-2011-301308
Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum
Andreas Charidimou (2011)
10.1016/J.NEUROL.2013.03.008
Angiopathie amyloïde : une forme précoce et agressive
S. Souvannanorath (2014)
10.1002/ana.23845
Pathogenesis of cerebral microbleeds: In vivo imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairment.
Jae-Hyun Park (2013)
10.1097/HJH.0000000000001913
Malignant hypertension: diagnosis, treatment and prognosis with experience from the Bordeaux cohort
Sébastien Rubin (2019)
10.1161/01.STR.26.8.1471
Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses.
Robert G. Hart (1995)
10.1016/J.PRANEU.2016.10.001
Diagnostic et prise en charge d’une angiopathie amyloïde cérébrale sporadique
Jean Capron (2016)
10.1161/01.STR.28.7.1418
Diagnosis of cerebral amyloid angiopathy. Sensitivity and specificity of cortical biopsy.
Steven M. Greenberg (1997)
10.1016/S1474-4422(10)70104-6
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges
Leonardo Pantoni (2010)
10.1056/NEJMoa1511939
A Randomized Trial of Intensive versus Standard Blood-Pressure Control.
Jackson T. Wright (2015)
10.1001/jama.2015.10082
Association Between Blood Pressure Control and Risk of Recurrent Intracerebral Hemorrhage.
Alessandro Biffi (2015)
10.1212/01.WNL.0000142966.22886.20
White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage
Eric E Smith (2004)
10.1016/S1474-4422(09)70013-4
Cerebral microbleeds: a guide to detection and interpretation
Steven M. Greenberg (2009)
10.1007/s00415-012-6520-8
Interest of CSF biomarker analysis in possible cerebral amyloid angiopathy cases defined by the modified Boston criteria
Dimitri Renard (2012)
10.1212/01.wnl.0000307750.41970.d9
Prevalence and risk factors of cerebral microbleeds
M. W. Vernooij (2008)
10.1161/STROKEAHA.110.595181
Prevalence and Risk Factors of Cerebral Microbleeds: An Update of the Rotterdam Scan Study
Mariëlle M. F. Poels (2010)
10.1007/s00415-008-0742-9
Intracerebral hemorrhage caused by cerebral amyloid angiopathy in a 53-year-old man
D. M. Campbell (2008)
10.1161/STROKEAHA.109.563932
Effects of Perindopril-Based Lowering of Blood Pressure on Intracerebral Hemorrhage Related to Amyloid Angiopathy: The PROGRESS Trial
Hisatomi Arima (2010)



Semantic Scholar Logo Some data provided by SemanticScholar